Deletion of endoplasmic reticulum stress-responsive co-chaperone p58 IPK protects mice from diet-induced steatohepatitis

• Published in: Hepatology research Vol. 48; no. 6; pp. 479 - 494
• Main Authors: Bandla, Harikrishna, Dasgupta, Debanjali, Mauer, Amy S, Nozickova, Barbora, Kumar, Swarup, Hirsova, Petra, Graham, Rondell P, Malhi, Harmeet
• Format: Journal Article
• Language: English
• Published: Netherlands 01.05.2018
• Subjects: fatty liver; hepatocyte apoptosis; endoplasmic reticulum stress
• ISSN: 1386-6346; 1872-034X
• DOI: 10.1111/hepr.13052

Activation of PKR-like endoplasmic reticulum kinase (PERK), an endoplasmic reticulum stress sensor, is a feature of non-alcoholic steatohepatitis (NASH), yet regulators of PERK signaling remain undefined in this context. The protein p58 regulates PERK; however, its role in NASH has not been examined. The aim of this study was to assess the in vivo role of p58 in the pathogenesis of dietary NASH. Parameters of hepatocyte cell death, liver injury, inflammation, fibrosis, indirect calorimetry and PERK activation were assessed in p58 knockout (p58 ) mice and their wild-type littermate controls. All animals were fed a diet enriched in fat, fructose, and cholesterol (FFC) for 20 weeks. Activation of PERK was attenuated in FFC-fed p58 mice. Accordingly, FFC-fed p58 mice showed a reduction in hepatocyte apoptosis and death receptor expression, with a significant reduction in serum alanine transaminase values. Correspondingly, macrophage accumulation and fibrosis were significantly lower in FFC-fed p58 mice. We have shown that, in an in vivo dietary NASH model, p58 mediates hepatocyte apoptosis and liver injury, likely through PERK phosphorylation. In the absence of p58 , PERK phosphorylation and NASH are attenuated. Inhibition of hepatic p58 could be a future target for NASH therapy.